Stephen Palmer

8PUBLICATIONS
42CO-AUTHORS
Epidemiological methodsEpidemiological modellingPredictive and prognostic markersMolecular targetsDiagnostic radiography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 02, 2026
Methods for information-sharing in network meta-analysis: Implications for inference and policy.

Georgios F Nikolaidis, Beth Woods, Stephen Palmer

|Aug 07, 2025
Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL.

Sam Harper, Daniela Afonso, Karina Watts

|Mar 12, 2024
Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective.

Thor-Henrik Brodtkorb, Christopher Knight, Farzam Kamgar

|Feb 22, 2024
Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo.

Siguroli Teitsson, Thor-Henrik Brodtkorb, Murat Kurt

|Dec 19, 2022
EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation.

Ana Duarte, Mark Corbett, Hollie Melton

|Jan 06, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.

Peter Murphy, David Glynn, Sofia Dias

Pageof 2

Frequent Collaborators

3 joint publications

Marta Soares

2 joint publications

Siguroli Teitsson

2 joint publications

Thor-Henrik Brodtkorb

2 joint publications

Mark Simmonds